Danielle Anderson
Senior Research Fellow, Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity (Australia)
Dr. Danielle Anderson is a Senior Research Fellow at the Peter Doherty Institute for Infection and Immunity. In January 2020, while located at Duke-NUS Medical School, Dr Anderson and her team isolated SARS-CoV-2 from a clinical sample from one of the first COVID-19 patients in Singapore. The team developed a serological assay for COVID-19 (now known as cPass, GenScript), which vitally assisted the Singapore authorities with contact tracing efforts.
Dr. Anderson’s research interests include understanding the virus/host relationship of a diverse group of medically important negative-stranded RNA viruses that includes Measles virus, Mumps virus and Nipah virus. These paramyxoviruses are not only responsible for a high degree of morbidity and mortality worldwide but also cause encephalitis. In addition, Dr. Anderson utilises novel diagnostic platforms for the identification of not only new paramyxoviruses, but also other clinically relevant emerging infectious diseases, such as coronaviruses.